Related references
Note: Only part of the references are listed.Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression
Kristen Fousek et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Immunohistochemistry for CCR4C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma
Keiichiro Fujii et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)
Absence of CCR2 reduces spontaneous intestinal tumorigenesis in the ApcMin/+ mouse model
Venkatakrishna Rao Jala et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis
Toni Celia-Terrassa et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment
Lingyun Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
Sarah Greene et al.
CLINICAL CANCER RESEARCH (2020)
CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway
Yang Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Joseph A. Flores-Toro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
Ha Thi Thu Do et al.
CANCERS (2020)
Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
Maria E. Reyes et al.
FRONTIERS IN IMMUNOLOGY (2020)
High CXCR3 on Leukemic Cells Distinguishes IgHVmut from IgHVunmut in Chronic Lymphocytic Leukemia: Evidence from CD5high and CD5low Clones
Gayane Manukyan et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
The CCL20-CCR6 Axis in Cancer Progression
Suguru Kadomoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Dina Morein et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cancer cell CCR2 orchestrates suppression of the adaptive immune response
Miriam R. Fein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Leukotrienes in Tumor-Associated Inflammation
Wen Tian et al.
FRONTIERS IN PHARMACOLOGY (2020)
Neutrophil: A New Player in Metastatic Cancers
Mengyue Wu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Antigens ofMycobacterium tuberculosisStimulate CXCR6+Natural Killer Cells
Jose Alberto Choreno-Parra et al.
FRONTIERS IN IMMUNOLOGY (2020)
Breast Cancer Cell-Neutrophil Interactions Enhance Neutrophil Survival and Pro-Tumorigenic Activities
Lingyun Wu et al.
CANCERS (2020)
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
Megan M. Tu et al.
COMMUNICATIONS BIOLOGY (2020)
Atypical chemokine receptors in tumor cell growth and metastasis
Bal L. Lokeshwar et al.
GPCR SIGNALING IN CANCER (2020)
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
Jan Korbecki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro
Yan Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy
Yan Nie et al.
CLINICAL CANCER RESEARCH (2019)
CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis
Bhawna Sharma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
Guangchen Liu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients
Valentina Marchica et al.
CANCERS (2019)
The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
Pier Adelchi Ruffini
FRONTIERS IN ONCOLOGY (2019)
Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients
Kerry-Ann McDonald et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Shangze Li et al.
CANCER RESEARCH (2019)
Metastasis Organotropism: Redefining the Congenial Soil
Yang Gao et al.
DEVELOPMENTAL CELL (2019)
CELLULAR SENESCENCE: AGING, CANCER, AND INJURY
Arianna Calcinotto et al.
PHYSIOLOGICAL REVIEWS (2019)
Cancer stemness, intratumoral heterogeneity, and immune response across cancers
Alex Miranda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel
Neeraj Kapur et al.
CANCER LETTERS (2019)
Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions
George S. Karagiannis et al.
CANCER RESEARCH (2019)
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Jiyeon Kim et al.
CELL METABOLISM (2019)
Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis
Hila Doron et al.
CELL REPORTS (2019)
Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression
Mohit Kumar Jolly et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma
Yaping Xu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Role of CXCR6-Deficient Natural Killer T Cells and CD4 T Cells in Hepatocarcinogenesis
Huan Tao et al.
GASTROENTEROLOGY (2019)
CXCR3 Identifies Human Naive CD8+ T Cells with Enhanced Effector Differentiation Potential
Gabriele De Simone et al.
JOURNAL OF IMMUNOLOGY (2019)
The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis
Ricardo Romero-Moreno et al.
NATURE COMMUNICATIONS (2019)
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Maria Teresa Masucci et al.
FRONTIERS IN ONCOLOGY (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
Elisabetta Marcuzzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
WonJae Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation
Min Yao et al.
MOLECULAR CANCER RESEARCH (2019)
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Yanjing Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Valeria Mollica Poeta et al.
FRONTIERS IN IMMUNOLOGY (2019)
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
Anna E. Vilgelm et al.
FRONTIERS IN IMMUNOLOGY (2019)
Support of Tumor Endothelial Cells by Chemokine Receptors
Nicole Salazar et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells
Namita Kundu et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2019)
Cellular senescence in cancer
Young Hwa Kim et al.
BMB REPORTS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy
Mingang Hao et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report
Ivana N. Micallef et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2
Han Xu et al.
CANCER LETTERS (2018)
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes
Younghun Jung et al.
CANCER RESEARCH (2018)
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
Xuanmao Jiao et al.
CANCER RESEARCH (2018)
Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer
Daniel O. Villarreal et al.
CANCER RESEARCH (2018)
Chemokines: the past, the present and the future
Peng Tang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease
Katia De Filippo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
A guide to chemokines and their receptors
Catherine E. Hughes et al.
FEBS JOURNAL (2018)
Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
David Linehan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling
Wen-Ze Qiu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
Sonia Pernas et al.
LANCET ONCOLOGY (2018)
A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models
Nicole Salazar et al.
MOLECULAR THERAPY (2018)
Metastatic niche functions and therapeutic opportunities
Toni Celia-Terrassa et al.
NATURE CELL BIOLOGY (2018)
The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
Yu Cheng et al.
TRANSLATIONAL ONCOLOGY (2018)
Hallmarks of Cellular Senescence
Alejandra Hernandez-Segura et al.
TRENDS IN CELL BIOLOGY (2018)
Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling
Rui Han et al.
SCIENTIFIC REPORTS (2018)
AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression
Binghao Li et al.
CANCER IMMUNOLOGY RESEARCH (2018)
CXCR7 Targeting and Its Major Disease Relevance
Chuan Wang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
Takanori Kitamura et al.
FRONTIERS IN IMMUNOLOGY (2018)
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
Mieke Metzemaekers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy
Laurent Beziaud et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors
David Argyle et al.
FRONTIERS IN IMMUNOLOGY (2018)
Genetic insights into the morass of metastatic heterogeneity
Kent W. Hunter et al.
NATURE REVIEWS CANCER (2018)
Inflammatory cytokine IL-8/CXCL8 promotes tumour escape from hepatocyte-induced dormancy
Ahmad S. Khazali et al.
BRITISH JOURNAL OF CANCER (2018)
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Xiaoguang Li et al.
GUT (2017)
Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis
Takamasa Yamamoto et al.
CLINICAL CANCER RESEARCH (2017)
CXCR5+ CD8+ T cells potently infiltrate pancreatic tumors and present high functionality
Minghui Bai et al.
EXPERIMENTAL CELL RESEARCH (2017)
CCR2 blockade alters the tumor microenvironment immune infiltrate and enhances anti-tumor activity in ovarian cancer
P. S. Binder et al.
GYNECOLOGIC ONCOLOGY (2017)
CD8+ T Cells Orchestrate pDC-XCR1+ Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming
Anna Brewitz et al.
IMMUNITY (2017)
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
Chiara Berlato et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
Helen L. Young et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Giovanni Luca Gravina et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Chemokine (C-C motif) ligand 21/C-C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial-mesenchymal transition via the extracellular signal-regulated kinase signaling pathway
Guangxin Zhong et al.
MOLECULAR MEDICINE REPORTS (2017)
Cell plasticity in epithelial homeostasis and tumorigenesis
Julia Varga et al.
NATURE CELL BIOLOGY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The yin and yang of leukotriene B4 mediated inflammation in cancer
Venkatakrishna R. Jala et al.
SEMINARS IN IMMUNOLOGY (2017)
An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells
Deyong Jia et al.
CELL DEATH & DISEASE (2017)
Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis (Review)
Zhiwei Zhao et al.
ONCOLOGY LETTERS (2017)
Senescent tumor cells lead the collective invasion in thyroid cancer
Young Hwa Kim et al.
NATURE COMMUNICATIONS (2017)
Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis
Kideok Jin et al.
ONCOTARGET (2017)
Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
Xixi Zhao et al.
ONCOTARGET (2017)
CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity
Kosuke Tanegashima et al.
EBIOMEDICINE (2017)
A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
Wenbo Yao et al.
EBIOMEDICINE (2017)
The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis
Songcheng Yin et al.
PLOS ONE (2017)
Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis
Neng Wang et al.
SCIENTIFIC REPORTS (2017)
Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination
Jean-Pierre Gagner et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer
Anne F. Schott et al.
CLINICAL CANCER RESEARCH (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies
Liyanage P. Perera et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells
Hui Wang et al.
CELL BIOCHEMISTRY AND FUNCTION (2017)
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
Antonella Sistigu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies
Shu-Hui Liu et al.
BLOOD ADVANCES (2017)
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Dingzhi Wang et al.
CANCER RESEARCH (2017)
Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Cc13
Elena Farmaki et al.
CANCER LETTERS (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
The breast tumor microenvironment alters the phenotype and function of natural killer cells
Tamara Krneta et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)
Xinxin Long et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
Baoping Guo et al.
BMC MEDICINE (2016)
Characteristics and Significance of the Pre-metastatic Niche
Yang Liu et al.
CANCER CELL (2016)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils
Yanfang Liu et al.
CANCER CELL (2016)
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
Tobias Eggert et al.
CANCER CELL (2016)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells
Bhawna Sharma et al.
CANCER LETTERS (2016)
CXCR4 and CCR7: Two eligible targets in targeted cancer therapy
Mohammad Amir Mishan et al.
CELL BIOLOGY INTERNATIONAL (2016)
Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications
Andrew R. Chin et al.
CLINICAL CANCER RESEARCH (2016)
The CXCL8-CXCR1/2 pathways in cancer
Qian Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Distinctive properties of metastasis-initiating cells
Toni Celia-Terrassa et al.
GENES & DEVELOPMENT (2016)
Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil
Junpu Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells
Lingxin Kong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
TNF- augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma
Kuang-Hui Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Atypical chemokine receptors in cancer: friends or foes?
Matteo Massara et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells
Fei Shen et al.
MOLECULAR CANCER RESEARCH (2016)
Platelet Interaction with Innate Immune Cells
Julia Barbara Kral et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)
Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells
Xin Tang et al.
TUMOR BIOLOGY (2016)
Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation
Tej Pratap Singh et al.
NATURE COMMUNICATIONS (2016)
CXCR2 signaling regulates KRAS(G12D)-induced autocrine growth of pancreatic cancer
Abhilasha Purohit et al.
ONCOTARGET (2016)
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Su Yin Lim et al.
ONCOTARGET (2016)
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity (vol 6, 2016)
John D. Martin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
Timothy Chao et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Maraviroc decreases CCL8-mediated migration of CCR5+ regulatory T cells and reduces metastatic tumor growth in the lungs
E. C. Halvorsen et al.
ONCOIMMUNOLOGY (2016)
CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway
Lirong Zhang et al.
PLOS ONE (2016)
The Role of CC-Chemokines in the Regulation of Angiogenesis
Anisyah Ridiandries et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Macrophage and Cancer Cell Cross-talk via CCR2 and CX3CR1 Is a Fundamental Mechanism Driving Lung Cancer
Anja Schmall et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy
Byung-Sik Cho et al.
BLOOD (2015)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
The Contribution of Angiogenesis to the Process of Metastasis
Diane R. Bielenberg et al.
CANCER JOURNAL (2015)
CXCR2/CXCL5 axis contributes to epithelial mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling
Shao-Lai Zhou et al.
CANCER LETTERS (2015)
VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner
Kien Pham et al.
CANCER LETTERS (2015)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
The role and modulation of CCR6+Th17 cell populations in rheumatoid arthritis
Sandra M. J. Paulissen et al.
CYTOKINE (2015)
An epigenetically distinct breast cancer cell subpopulation promotes collective invasion
Jill M. Westcott et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
Takanori Kitamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases
Han-Sin Jeong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
Elvin Wagenblast et al.
NATURE (2015)
ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells
Weiran Gao et al.
TUMOR BIOLOGY (2015)
Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition
Ke-Zhu Hou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Ervin E. Kara et al.
NATURE COMMUNICATIONS (2015)
Pancreatic Cancer Metastases Harbor Evidence of Polyclonality
Ravikanth Maddipati et al.
CANCER DISCOVERY (2015)
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling
Laura Brandolini et al.
ONCOTARGET (2015)
Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases
Han-Sin Jeong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
Heiyoun Jung et al.
Journal for ImmunoTherapy of Cancer (2015)
Host Cxcr2-dependent regulation of mammary tumor growth and metastasis
Bhawna Sharma et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models
Sheng-Bin Peng et al.
MOLECULAR CANCER THERAPEUTICS (2015)
CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
Bharat Devapatla et al.
PLOS ONE (2015)
Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis
Deepika Neelakantan et al.
CELL ADHESION & MIGRATION (2015)
The landscape of metastatic progression patterns across major human cancers
Jan Budczies et al.
ONCOTARGET (2015)
Tumorigenesis: it takes a village
Doris P. Tabassum et al.
NATURE REVIEWS CANCER (2015)
Metastasis prevention by targeting the dormant niche
Cyrus M. Ghajar
NATURE REVIEWS CANCER (2015)
Immune cell promotion of metastasis
Takanori Kitamura et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis
Weiying Zhou et al.
CANCER CELL (2014)
CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition
Xian-Shuo Cheng et al.
CANCER LETTERS (2014)
Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
David G. McFadden et al.
CELL (2014)
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Nicola Aceto et al.
CELL (2014)
A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer
Matthew D. Galsky et al.
CLINICAL CANCER RESEARCH (2014)
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Josef Ehling et al.
GUT (2014)
Non-tumorigenic epithelial cells secrete MCP-1 and other cytokines that promote cell division in breast cancer cells by activating ERα via PI3K/Akt/mTOR signaling
Maria Riverso et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation
Nicole Salazar et al.
MOLECULAR CANCER (2014)
Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers
Allison S. Cleary et al.
NATURE (2014)
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
Diletta Di Mitri et al.
NATURE (2014)
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Laura Bonapace et al.
NATURE (2014)
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
Sandra S. McAllister et al.
NATURE CELL BIOLOGY (2014)
CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma
Fei Li et al.
MEDICAL ONCOLOGY (2014)
Inflammatory chemokines and metastasis-tracing the accessory
L. Borsig et al.
ONCOGENE (2014)
Live Imaging and Gene Expression Analysis in Zebrafish Identifies a Link between Neutrophils and Epithelial to Mesenchymal Transition
Christina M. Freisinger et al.
PLOS ONE (2014)
A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity
Matthew P. Ablett et al.
ONCOTARGET (2014)
The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases
Lianyu Chen et al.
SCIENTIFIC REPORTS (2014)
Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion
Anna Chapman et al.
CELL REPORTS (2014)
Mesenchymal Stem Cell-Induced Doxorubicin Resistance in Triple Negative Breast Cancer
Dar-Ren Chen et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
The depletion of Interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells
Nan Shao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Yibin Kang et al.
CANCER CELL (2013)
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K. Sandhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Bridget Charbonneau et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
Zachary C. Hartman et al.
CANCER RESEARCH (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
Jagdeep K. Singh et al.
CLINICAL CANCER RESEARCH (2013)
Recruitment of a Myeloid Cell Subset (CD11b/Gr1mid) via CCL2/CCR2 Promotes the Development of Colorectal Cancer Liver Metastasis
Lei Zhao et al.
HEPATOLOGY (2013)
Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions
Yan Wu et al.
HEPATOLOGY (2013)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Alexandre Iannello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis
Jiao Zheng et al.
MOLECULAR CANCER (2013)
Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis
Bhawna Sharma et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
Xiaoyang Ling et al.
PLOS ONE (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Chemokines in tumor progression and metastasis
Purvaba J. Sarvaiya et al.
ONCOTARGET (2013)
Macrophages and chemokines as mediators of angiogenesis
Jennifer L. Owen et al.
FRONTIERS IN PHYSIOLOGY (2013)
Immune regulation by atypical chemokine receptors
Robert J. B. Nibbs et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The evolution of the cancer niche during multistage carcinogenesis
Mary Helen Barcellos-Hoff et al.
NATURE REVIEWS CANCER (2013)
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
Geoffrey L. Uy et al.
BLOOD (2012)
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
Daniel J. Dairaghi et al.
BLOOD (2012)
Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production
Zhi Shi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
A. Dubrovska et al.
BRITISH JOURNAL OF CANCER (2012)
The metastatic niche and stromal progression
Jonathan P. Sleeman
CANCER AND METASTASIS REVIEWS (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
Monika Julia Wolf et al.
CANCER CELL (2012)
CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
Akihiro Tsuyada et al.
CANCER RESEARCH (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum
Ingrid U. Schraufstatter et al.
IMMUNOLOGY (2012)
CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms
Wei Bin Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
Toni Celia-Terrassa et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Hector Peinado et al.
NATURE MEDICINE (2012)
Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells
K. E. Luker et al.
ONCOGENE (2012)
CXCR4 Expression in Prostate Cancer Progenitor Cells
Anna Dubrovska et al.
PLOS ONE (2012)
Fibroblast Growth Factor Receptor 1 Activation in Mammary Tumor Cells Promotes Macrophage Recruitment in a CX3CL1-Dependent Manner
Johanna R. Reed et al.
PLOS ONE (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
The role of XCR1 and its liganc XCL1 in antigen cross-presentation by murine and human dendritic cells
Richard A. Kroczek et al.
FRONTIERS IN IMMUNOLOGY (2012)
Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells
Jhen-Wei Ruan et al.
BREAST CANCER RESEARCH (2012)
Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib
Davorka Messmer et al.
BLOOD (2011)
Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs
Qing Chen et al.
CANCER CELL (2011)
IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells
Romaine I. Fernando et al.
CANCER RESEARCH (2011)
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Elda Righi et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
Jo Vandercappellen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells
Lyndsay V. Rhodes et al.
EXPERIMENTAL CELL RESEARCH (2011)
Chemokines as targets for therapy
Alexandre Garin et al.
EXPERIMENTAL CELL RESEARCH (2011)
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)
Mickael Ohanna et al.
GENES & DEVELOPMENT (2011)
CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation
Seema Singh et al.
MICROVASCULAR RESEARCH (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
AMBIGUOUS CELLS: THE EMERGENCE OF THE STEM CELL CONCEPT IN THE NINETEENTH AND TWENTIETH CENTURIES
Andreas-Holger Maehle
NOTES AND RECORDS OF THE ROYAL SOCIETY (2011)
Differential Estrogen-Regulation of CXCL12 Chemokine Receptors, CXCR4 and CXCR7, Contributes to the Growth Effect of Estrogens in Breast Cancer Cells
Antoine Boudot et al.
PLOS ONE (2011)
CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma
Bao-Cheng Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Homeostatic chemokine receptors and organ-specific metastasis
Albert Zlotnik et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths
Marjon A. Smit et al.
AGING-US (2010)
A critical role of CCR7 in invasiveness and metastasis of SW620 colon cancer cell in vitro and in vivo
Yu Shuyi et al.
CANCER BIOLOGY & THERAPY (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
S. Liekens et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
CXCL8 and its cognate receptors in melanoma progression and metastasis
Seema Singh et al.
FUTURE ONCOLOGY (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction
Mingzhu Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance
Kanya Honoki et al.
ONCOLOGY REPORTS (2010)
Fractalkine-Induced Endothelial Cell Migration Requires MAP Kinase Signaling
Michael V. Volin et al.
PATHOBIOLOGY (2010)
Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model
Takanori Kitamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Expression of the C-C Chemokine Receptor 7 Mediates Metastasis of Breast Cancer to the Lymph Nodes in Mice
Heather D. Cunningham et al.
TRANSLATIONAL ONCOLOGY (2010)
High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors
Laureen S. Ojalvo et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation
Thomas T. Murooka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Bruno Nervi et al.
BLOOD (2009)
Positive Feedback Activation of Estrogen Receptors by the CXCL12-CXCR4 Pathway
Karine Sauve et al.
CANCER RESEARCH (2009)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Expression of chemokine receptors CXCR4, CXCR5 and CCR7 on B and T lymphocytes from patients with primary antibody deficiency
D. Payne et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology
Richard M. Ransohoff
IMMUNITY (2009)
The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer
Pirus Ghadjar et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex
Daniel Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development
Yu-Mei Ding et al.
ONCOLOGY REPORTS (2009)
A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth
Binzhi Qian et al.
PLOS ONE (2009)
The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
Merav Darash-Yahana et al.
PLOS ONE (2009)
Co-evolution of tumor cells and their microenvironment
Kornelia Polyak et al.
TRENDS IN GENETICS (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer
Nikolas H. Stoecklein et al.
CANCER CELL (2008)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia
Jewon Ryu et al.
CARDIOVASCULAR RESEARCH (2008)
Chemokine signaling via the CXCR2 receptor reinforces senescence
Juan C. Acosta et al.
CELL (2008)
Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine
Farin F. Amersi et al.
CLINICAL CANCER RESEARCH (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: Implications for therapy
Jun Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Opinion - Is cell competition relevant to cancer?
Eduardo Moreno
NATURE REVIEWS CANCER (2008)
Down-regulation of surface fractalkine by RNA interference in B16 melanoma reduced tumor growth in mice
Tong Ren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Chemokines in tumor angiogenesis and metastasis
Seema Singh et al.
CANCER AND METASTASIS REVIEWS (2007)
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts
Sonia Vallet et al.
BLOOD (2007)
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
K. Kawada et al.
ONCOGENE (2007)
Manipulating the chemokine-chemokine receptor network to treat cancer
Pier A. Ruffini et al.
CANCER (2007)
CCR2 expression correlates with prostate cancer progression
Yi Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption
Yi Lu et al.
CANCER RESEARCH (2007)
Cancer as an evolutionary and ecological process
Lauren M. F. Merlo et al.
NATURE REVIEWS CANCER (2006)
Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways
Seon-Jin Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver
Joost Meijer et al.
CANCER RESEARCH (2006)
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor
Svetlana M. Stamatovic et al.
JOURNAL OF IMMUNOLOGY (2006)
Cancer CXC chemokine networks and tumour angiogenesis
RM Strieter et al.
EUROPEAN JOURNAL OF CANCER (2006)
Role of tumor-associated macrophages in tumor progression and invasion
Alberto Mantovani et al.
CANCER AND METASTASIS REVIEWS (2006)
Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer
JT Kaifi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment
T Kuroda et al.
CLINICAL CANCER RESEARCH (2005)
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A
ML Varney et al.
MELANOMA RESEARCH (2005)
Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics
SK Bromley et al.
NATURE IMMUNOLOGY (2005)
Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis
J Hwang et al.
CYTOKINE (2005)
The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed
L Riol-Blanco et al.
JOURNAL OF IMMUNOLOGY (2005)
Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8
R Schruefer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A
KH Hong et al.
BLOOD (2005)
Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/CCL2 and Interleukin-8/CXCL8 in endothelial cells during angiogenesis
BG Gálvez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A1
P Scapini et al.
JOURNAL OF IMMUNOLOGY (2004)
Functional CCR9 expression is associated with small intestinal metastasis
A Letsch et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Expression and functional role of CCR9 in prostate cancer cell migration and invasion
S Singh et al.
CLINICAL CANCER RESEARCH (2004)
Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo
JS Hwang et al.
FEBS LETTERS (2004)
Inhibition of fractalkine ameliorates murine collagen-induced arthritis
T Nanki et al.
JOURNAL OF IMMUNOLOGY (2004)
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
A Sparmann et al.
CANCER CELL (2004)
CXC chemokines in angiogenesis of cancer
RM Strieter et al.
SEMINARS IN CANCER BIOLOGY (2004)
CCL16 activates an angiogenic program in vascular endothelial cells
M Strasly et al.
BLOOD (2004)
High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma
T Kondo et al.
JOURNAL OF UROLOGY (2004)
Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells
S Fujiyama et al.
CIRCULATION RESEARCH (2003)
Immune evasion by murine melanoma mediated through CC chemokine receptor-10
T Murakami et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
L Lasagni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells
JM Hall et al.
MOLECULAR ENDOCRINOLOGY (2003)
Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
QH Ye et al.
NATURE MEDICINE (2003)
Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas
PR Lu et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
C Combadière et al.
CIRCULATION (2003)
CXCRA is a major chemokine receptor on glioma cells and mediates their survival
Y Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses
M Locati et al.
ALLERGY (2002)
Expression of the fractalkine receptor (CX3CR1) in human kidney diseases
S Segerer et al.
KIDNEY INTERNATIONAL (2002)
Tumor-associated macrophages: a molecular perspective
A Sica et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
The role of chemokines in melanoma tumor growth and metastasis
AS Payne et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature
PM Murphy
PHARMACOLOGICAL REVIEWS (2002)
Somatic stem cell plasticity: Current evidence and emerging concepts
GG Wulf et al.
EXPERIMENTAL HEMATOLOGY (2001)
Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma
HE Wiley et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Fractalkine: A novel angiogenic chemokine in rheumatoid arthritis
MV Volin et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Role of fractalkine in leukocyte adhesion and migration and in vascular injury
H Umehara et al.
DRUG NEWS & PERSPECTIVES (2001)
Chemokines and the molecular basis of cancer metastasis.
PM Murphy
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor
CH Jenh et al.
CYTOKINE (2001)
Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells
R Salcedo et al.
JOURNAL OF IMMUNOLOGY (2001)
Heterogeneous vascular dependence of tumor cell populations
JL Yu et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) αβ+CD8+ single-positive T cells, TCRγδ+ T cells, and natural killer-type cells in human thymus
P Romagnani et al.
BLOOD (2001)
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
CL Addison et al.
JOURNAL OF IMMUNOLOGY (2000)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Share Paper
